Illinois-based spirits company Beam Inc. is investigating possible FCPA violations in India, according to a report Friday by the Times of India.
Whistleblower complaints triggered the investigation into ‘excise duty violations, invoicing problems, and handing over distribution in some key markets,’ the report said.… Continue Reading
U.K.-based medical device maker Smith & Nephew plc agreed to pay $22.2 million to settle Foreign Corrupt Practices Act offenses committed by its U.S. and German subsidiaries.
The company admitted bribing government-employed doctors in Greece for more than a decade to win business.… Continue Reading
The debate about medical ghosting has focused on the U.S. market. But could the DOJ and SEC now be looking at the practice overseas, where it might violate the FCPA?
No good deed goes unpunished, or so the saying goes. That sure came true for Schering-Plough a few years ago. From February 1999 to March 2002, the New Jersey-based maker of Afrin, Claritin, Coricidin and Cipro, among other leading drugs, violated the Foreign Corrupt Practices Act through overseas charitable giving.… Continue Reading